This operational measure of multimorbidity, which can be implemented using either or both clinical and administrative data, may facilitate its monitoring and international comparison. Once validated, it may enable the advancement and evolution of conceptual and theoretical aspects of multimorbidity that will eventually lead to better care.
No takes yet. Share an insight, caveat, or question.
Calderón‐Larrañaga et al. (2016) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: